Drug-induced cutaneous lupus erythematosus: 88 new cases
- 1 January 2017
- journal article
- research article
- Published by John Libbey Eurotext in European Journal Of Dermatology
- Vol. 27 (1), 28-33
- https://doi.org/10.1684/ejd.2016.2912
Abstract
Background: An increasing number of drugs have been linked to drug-induced subacute cutaneous lupus erythematosus (DI-SCLE). The recognition and management of DI-SCLE can be challenging, as the condition may be triggered by different classes of drugs after variable lengths of time. Objectives. To determine the proportion of patients with cutaneous lupus erythematosus (CLE) whose drugs are an inducing or aggravating factor. Materials & methods: We conducted a retrospective chart review of patients diagnosed with CLE at a dermatological department over a 21-year period. We registered clinical, serological, and histological data with a focus on drug intake. Results: Of 775 consecutive patients with a diagnosis of lupus erythematosus (LE) or suspected LE, a diagnosis of CLE could be confirmed in 448 patients. A total of 130 patients had a drug intake that could suggest DI-SCLE. In 88 cases, a drugwas evaluated to be definitely, probably, or possibly triggering CLE using the Naranjo probability scale. The most common drugs involved were proton pump inhibitors (PPIs), thiazide diuretics, anti-fungals, chemotherapeutics, statins, and antiepileptics. The incubation period varied widely with a median of eight weeks. The characteristics of DI-SCLE patients were more widespread rash relative to the other patients, with inflamed skin lesions or atypical variants which could resemble erythema multiforme. Conclusions: We present 88 patients with DI-SCLE, which is the largest case series reported, to date. DISCLE represented 20% of patients with CLE seen at our department. We conclude that DI-SCLE should be considered in every case of SCLE.Keywords
This publication has 26 references indexed in Scilit:
- Lupus erythematosus–like skin eruption after vemurafenib therapyJournal of the American Academy of Dermatology, 2014
- Lupus eritematoso inducido por fármacosActas Dermo-Sifiliograficas, 2014
- Subacute Cutaneous Lupus Erythematosus Induced by ChemotherapyJAMA Dermatology, 2013
- Cutaneous lupus erythematosus: First multicenter database analysis of 1002 patients from the European Society of Cutaneous Lupus Erythematosus (EUSCLE)Autoimmunity Reviews, 2013
- Drug-induced subacute cutaneous lupus erythematosus associated with doxorubicinJournal of the American Academy of Dermatology, 2012
- Subacute cutaneous lupus erythematosus and its association with drugs: a population-based matched case-control study of 234 patients in SwedenBritish Journal of Dermatology, 2012
- Chilblain lupus induced by TNF-α antagonists: a case report and literature reviewClinical Rheumatology, 2011
- Drug-induced subacute cutaneous lupus erythematosus: evidence for differences from its idiopathic counterpartBritish Journal of Dermatology, 2011
- A systematic review of drug-induced subacute cutaneous lupus erythematosusBritish Journal of Dermatology, 2010
- Drug-induced lupus erythematosusArchiv für dermatologische Forschung, 2008